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After adjusting for age, ejection fraction and prior MI, the combination of
IVCD and antiarrhythmic drug remains a significant predictor of increased
mortality (hazard ratio 1.69, P ~ 0.04).
Conclusion Antiarrhythmic drug use is associated with and possibly a
cause of increased mortality and arrhythmic deaths in patients with an IVCD.
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simultaneously. Following imaging, the slices were fixed in formaldehyde
then stored at 4'C in 30% sucrose/phosphate buffer until processing for im-
munohistochemistry.
All of the hearts showed homogeneous thallium perfusion, however there
was evidence of a regional decrease in MIBG uptake ranging from 10% to
45% of the left ventricle, consistent with regional denervation. The defects
were generally localized to the anterior and septal territories. Immunocy-
tochemial studies on sections from regions with decreased MIBG uptake
showed a striking paucity of nerves compared to regions with normal MIBG
uptake, confirming denelVation. While all of the hearts showed denelVation,
2/3 with severe arrhythmia showed either extensive denervation or a steep
gradient in MIBG uptake, while 1/4 of the mildly affected or dogs without
arrhythmias showed extensive denervation.
We conclude that there is abnormal heterogeneous sympathetic innerva-
tion in this population of dogs with spontaneous naturally occurring ven-
tricular arrhythmias and increased incidence of sudden cardiac death. This
heterogeneity of innervation may playa role in the etiology of ventricular
arrhythmia, particularly during states of increased sympathetic tone,
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Conclusion. The negative dromotropic effect of VS, VS during SS and ISO
is attenuated by L-NMMA and restored toward baseline by L-arginine, sug-
gesting that NO plays a partial role at both prejunctional and postjunctional
sites in the vagal modulation of AV nodal conduction.
Arif Elvan, Harald P. Pride, Douglas P. Zipes. lVannertlnstitute of Cardiology,
Indianapolis, IN
Introduction. Nitric oxide (NO), synthesized from L-arginine, is involved in the
modulation of autonomic neurotransmission. Recent in vitro and in vivo stud-
ies have shown that the negative chronotropic effect of carbachol or vagal
stimulation was partially blocked by an L-arginine analog, NG-monomethyl-
L-arginine (L-NMMA), that competetively inhibits NO synthase (NOS). The
purpose of the present study was to assess in an open chest canine model
whether the L-arginine-NO pathway may also playa role in the autonomic
modulation of AV nodal conduction, and if so, whether this is prejunctional
or postjunctional.
Methods and Results. To test for prejunctional actions, we assessed the
dromotropic response to cervical vagal stimulation (VS: 2 Hz, 4.0 V. 4 ms)
and VS during ansae subclaviae stimulation (SS: 2 Hz, 3.0 V. 4 ms, n = 5).
To test for postjunctional actions, we determined the dromotropic response
to intravenous isoproterenol infusion (5 mcg/min) before and during vagal
stimulation (VS + ISO, n = 5). VS, SS and ISO were repeated during selec-
tive infusion of L-NMMA retrogradely into the AV node artery (AVNA) and
following reversal of NOS inhibition with L-arginine (100 mg/kg). Shown is
the change in AV nodal conduction time (AH, msec) produced by VS before
and during SS or isoproterenol at control state (saline infusion into AVNA, 1
ml!min), during L-NMMA infusion (4 mg/min) into AVNA, and after IV injection
of L-arginine (100 mg/kg).
*p < 0.01 vs baseline, t p < 0.01 vs L-NMMA
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Background: Torsade de pointes (TDP) is thought to result from early af-
terdepolarizations (EADs). Although it has been shown that adenosine can
suppress catecholamine-induced EADs in isolated guinea pig ventricular my-
ocytes, its effects on TDP in vivo are uncertain.
Methods: TDP was induced in 25 anesthetized rabbits weighing 3-4 kg
by simultaneous intravenous infusion of methoxamine, an <'1-adrenoceptor
agonist (70 nmol/kg/minl, and clofilium, a blocker of the delayed rectifier K+
channel (76 nmol/kg/minl. AfterTDP was initiated, saline (n = 6) orthe adeno-
sine Al receptor agonist R-phenylisopropyladenosine (R-PIA, 1.3 mg/kg, n =
61 was infused. Two additional groups were pretreated with propranolol (2
/-Lmol/kg, n = 7), a ,Il-adrenoceptor blocker, or glibenclamide (10 /-Lmol/kg, n
= 6). an ATP sensitive K+ channel (IK-ATP) blocker. prior to R-PIA infusion.
Results:
Suppression of TOP
Adenosine Al Receptor Activation Suppresses
Torsade De Pointes by Opening ATP Sensitive K+
Channels in Rabbits
Hanno L. Tan. Charles J,y' Hou, Eric Adler, Ruey J, Sung. Stanford University Medical
Center. Stanford, CA
Suppression of TDP in the R-PIA and the R-PIA/propranolol groups was not
associated with shortening of the OT interval (baseline: 205 ± 9 ms, onset of
TDP: 344 ± 10 ms, after suppression of TDP: 400 ± 40 ms [p < NS vs onset
of TDP). mean ± SD). but with reduction of OT interval dispersion (2.7 ±
0,5%,7,5 ± 1,1 %, and 4.2 ± 0,7% [p < 0.05 vs onset of TDP], respectively).
as measured from 6 limb leads.
Conclusion: Adenosine A, receptor activation suppresses TDP induced
by K+ channel blockade primarily by opening IK-ATP, rather than byantago-
nizing ,Il-adrenoceptor mediated mechanisms. This effect is associated with
reduced OT interval dispersion, but not with OT interval shortening.
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An inbred colony of German Shepherd dogs with spontaneous ventricular ar-
rhythmias and sudden death has recently been identified. The median age of
onset of the arrhythmia (4.5 months), the tendency for sudden death to occur
during REM sleep, duringffollowing exercise, and the absence of structural
heart disease suggest a developmental abnormality of the autonomic inner-
vation to the heart. To further evaluate this possibility, we studied 7 dogs from
this colony, mean age 5.2 months. Three of seven were severely affected
(frequent VT on holter). two were mildly affected, and two had no arrhyth-
mias by holter analysis. We imaged the distribution of functional myocardial
sympathetic innervation and perfusion using 1-123 metaiodobenzylguanidine
(MIBG) and thallium-201 respectively. Sympathetic nerve distribution was
evaluated morphologically by immunocytochemical localization of tyrosine
hydroxylase. Six mCi of 1-123 M IBG was injected IV followed three hours later
by 2 mCi of thallium-201. The hearts were excised, sliced transversely, and
imaged directly for MIBG and thallium. Color functional maps were derived
to display the distribution of innervation (MIBG) and perfusion (thallium-2011
Kurt C. Fabrick, Murray A. Mittleman, Joel Tsevat, Paula A. Goldman, Larry
W. Williams, Lee Goldman, Milton C. Weinstein, Brigham and Women's Hospital,
Harvard Medical School and the Harvard School ofPublic Health. Boston, MA
Two recent epidemiologic studies reported that subjects taking vitamin E(vit
E) supplements had about a 40% reduction in major coronary heart disease
(CHD) events compared with those in the lowest quintile of Vit E intake. The
Coronary Heart Disease Policy Model (CHDPM). a comprehensive computer
simulation of the costs and consequences of CHD in the US, was used to
analyze the cost-effectiveness of vit E.
The CHDPM uses age- and gender-specific distributions of CHD risk fac-
tors and age-, gender-, and risk factor-specific probabilities of disease onset
to estimate CHD and non-CHD death and morbidity. The CHDPM simulation
estimated the incremental cost-effectiveness (C/E) and the potential years of
life saved for primary (1 ') and secondary (2') prevention over 5 and 10 years.
The cost of therapy with vit E (200 IU/day) was set at $56.07/year.
For 2' prevention assuming the full efficacy observed in epidemiologic
studies, vit E saves both years of life and costs because of CHD averted,
Even at 1I8th efficacy (Men RR = 0.97, Women RR = 0,95). the incremental
C/E was $9,400 per year of life saved (YOLS) for men and $2,200 for women.
